Frontier Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,782
| Closed | -$1.9M | – | 290 |
|
|
2020
Q3 | $1.9M | Sell |
19,782
-20,580
| -51% | -$1.98M | 0.02% | 282 |
|
|
2020
Q2 | $4.92M | Buy |
+40,362
| New | +$4.92M | 0.04% | 259 |
|
|
2019
Q2 | – | Sell |
-188,328
| Closed | -$16.6M | – | 299 |
|
|
2019
Q1 | $16.6M | Sell |
188,328
-175,144
| -48% | -$15.4M | 0.12% | 205 |
|
|
2018
Q4 | $26M | Sell |
363,472
-42,242
| -10% | -$3.02M | 0.21% | 151 |
|
|
2018
Q3 | $49.9M | Sell |
405,714
-241,209
| -37% | -$29.7M | 0.32% | 125 |
|
|
2018
Q2 | $63.6M | Sell |
646,923
-179,349
| -22% | -$17.6M | 0.45% | 83 |
|
|
2018
Q1 | $68.5M | Buy |
826,272
+706,047
| +587% | +$58.6M | 0.5% | 68 |
|
|
2017
Q4 | $9.33M | Buy |
+120,225
| New | +$9.33M | 0.07% | 233 |
|